C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 403/10 (2006.01) A61K 31/55 (2006.01) A61K 31/553 (2006.01) A61P 3/04 (2006.01) A61P 25/20 (2006.01) C07D 401/14 (2006.01) C07D 413/10 (2006.01) C07D 413/14 (2006.01) C07D 417/10 (2006.01) C07D 417/14 (2006.01)
Patent
CA 2739927
The present invention is directed to disubstituted azepan and oxazepan amide compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
La présente invention concerne des azépane- et oxazépaneamides disubstitués qui sont des antagonistes des récepteurs de l'orexine, et qui peuvent être employés dans le traitement prophylactique ou thérapeutique de pathologies et de troubles neurologiques et psychiatriques faisant intervenir les récepteurs de l'orexine. La présente invention concerne également des compositions pharmaceutiques comprenant lesdits composés, ainsi que l'emploi desdits composés et compositions dans le traitement prophylactique ou thérapeutique de pathologies faisant intervenir les récepteurs de l'orexine.
Cox Christopher D.
Fraley Mark E.
Schreier John D.
Merck Sharp & Dohme Corp.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Disubstituted azepan orexin receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Disubstituted azepan orexin receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Disubstituted azepan orexin receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1705849